ID   SIA7B_HUMAN             Reviewed;         374 AA.
AC   Q9UJ37; Q12971;
DT   11-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   28-JUN-2023, entry version 172.
DE   RecName: Full=Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2;
DE            EC=2.4.3.3 {ECO:0000269|PubMed:10742600, ECO:0000269|PubMed:29251719};
DE   AltName: Full=GalNAc alpha-2,6-sialyltransferase II;
DE   AltName: Full=ST6GalNAc II {ECO:0000303|PubMed:10742600};
DE            Short=ST6GalNAcII {ECO:0000303|PubMed:29251719};
DE   AltName: Full=SThM;
DE   AltName: Full=Sialyltransferase 7B;
DE            Short=SIAT7-B;
GN   Name=ST6GALNAC2; Synonyms=SIAT7B, SIATL1, STHM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, PATHWAY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RX   PubMed=10742600; DOI=10.1016/s0304-4165(00)00020-9;
RA   Samyn-Petit B., Krzewinski-Recchi M.A., Steelant W.F.A., Delannoy P.,
RA   Harduin-Lepers A.;
RT   "Molecular cloning and functional expression of human ST6GalNAc II.
RT   Molecular expression in various human cultured cells.";
RL   Biochim. Biophys. Acta 1474:201-211(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary gland;
RA   Sotiropoulou G., Anisowicz A., Sager R.;
RT   "Isolation and cloning from human mammary epithelial cells of a complete
RT   cDNA sequence homologous to other known sialyltransferases.";
RL   Submitted (SEP-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0007744|PDB:6APJ, ECO:0007744|PDB:6APL}
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) IN COMPLEX WITH CMP, FUNCTION,
RP   CATALYTIC ACTIVITY, PATHWAY, BIOPHYSICOCHEMICAL PROPERTIES, GLYCOSYLATION
RP   AT ASN-85; ASN-130 AND ASN-161, AND DISULFIDE BONDS.
RX   PubMed=29251719; DOI=10.1038/nchembio.2539;
RA   Moremen K.W., Ramiah A., Stuart M., Steel J., Meng L., Forouhar F.,
RA   Moniz H.A., Gahlay G., Gao Z., Chapla D., Wang S., Yang J.Y.,
RA   Prabhakar P.K., Johnson R., Rosa M.D., Geisler C., Nairn A.V.,
RA   Seetharaman J., Wu S.C., Tong L., Gilbert H.J., LaBaer J., Jarvis D.L.;
RT   "Expression system for structural and functional studies of human
RT   glycosylation enzymes.";
RL   Nat. Chem. Biol. 14:156-162(2018).
RN   [6]
RP   INVOLVEMENT IN IGA NEPHROPATHY.
RX   PubMed=19357720; DOI=10.1038/ki.2009.99;
RA   Zhu L., Tang W., Li G., Lv J., Ding J., Yu L., Zhao M., Li Y., Zhang X.,
RA   Shen Y., Zhang H., Wang H.;
RT   "Interaction between variants of two glycosyltransferase genes in IgA
RT   nephropathy.";
RL   Kidney Int. 76:190-198(2009).
CC   -!- FUNCTION: Catalyzes the transfer of N-acetylneuraminyl groups onto
CC       glycan chains in glycoproteins (PubMed:10742600, PubMed:29251719).
CC       Shows a preference for N-acetylgalactosamine (GalNAc) residues already
CC       modified by the addition of galactose or galactose followed by sialic
CC       acid in alpha-2,3 linkage (PubMed:10742600).
CC       {ECO:0000269|PubMed:10742600, ECO:0000269|PubMed:29251719}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl
CC         derivative + CMP-N-acetyl-beta-neuraminate = a beta-D-galactosyl-
CC         (1->3)-[N-acetyl-alpha-neuraminyl-(2->6)]-N-acetyl-alpha-D-
CC         galactosaminyl derivative + CMP + H(+); Xref=Rhea:RHEA:11136,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57812, ChEBI:CHEBI:60377,
CC         ChEBI:CHEBI:133470, ChEBI:CHEBI:140764; EC=2.4.3.3;
CC         Evidence={ECO:0000269|PubMed:10742600, ECO:0000269|PubMed:29251719};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11137;
CC         Evidence={ECO:0000269|PubMed:10742600, ECO:0000269|PubMed:29251719};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=130 uM for CMP-N-acetylneuraminate {ECO:0000269|PubMed:10742600};
CC         KM=104 uM for CMP-N-acetylneuraminate {ECO:0000269|PubMed:29251719};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:10742600, ECO:0000269|PubMed:29251719}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000305}; Single-
CC       pass type II membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal muscle, heart, kidney,
CC       placenta, lung and leukocytes. {ECO:0000269|PubMed:10742600}.
CC   -!- MISCELLANEOUS: Aberrant O-galactosylation of IgA1 molecules plays a
CC       role in the development and progression of IgA nephropathy (IgAN).
CC       Genetic interactions of C1GALT1 and ST6GALNAC2 variants influence IgA1
CC       O-glycosylation, disease predisposition, and disease severity, and may
CC       contribute to the polygenic nature of IgAN.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 29 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; Note=ST6GalNAc
CC       II;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_631";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ251053; CAB61434.1; -; mRNA.
DR   EMBL; U14550; AAA52228.1; -; mRNA.
DR   EMBL; BT019972; AAV38775.1; -; mRNA.
DR   EMBL; BC040455; AAH40455.1; -; mRNA.
DR   CCDS; CCDS11747.1; -.
DR   RefSeq; NP_006447.2; NM_006456.2.
DR   PDB; 6APJ; X-ray; 3.10 A; A/B/C/D/E/F=1-374.
DR   PDB; 6APL; X-ray; 2.35 A; A/B/C/D/E/F=1-374.
DR   PDBsum; 6APJ; -.
DR   PDBsum; 6APL; -.
DR   AlphaFoldDB; Q9UJ37; -.
DR   SMR; Q9UJ37; -.
DR   BioGRID; 115856; 3.
DR   IntAct; Q9UJ37; 1.
DR   MINT; Q9UJ37; -.
DR   STRING; 9606.ENSP00000225276; -.
DR   CAZy; GT29; Glycosyltransferase Family 29.
DR   GlyCosmos; Q9UJ37; 4 sites, 1 glycan.
DR   GlyGen; Q9UJ37; 4 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UJ37; -.
DR   PhosphoSitePlus; Q9UJ37; -.
DR   BioMuta; ST6GALNAC2; -.
DR   DMDM; 21759448; -.
DR   EPD; Q9UJ37; -.
DR   MassIVE; Q9UJ37; -.
DR   MaxQB; Q9UJ37; -.
DR   PaxDb; Q9UJ37; -.
DR   PeptideAtlas; Q9UJ37; -.
DR   ProteomicsDB; 84582; -.
DR   Antibodypedia; 32441; 114 antibodies from 20 providers.
DR   DNASU; 10610; -.
DR   Ensembl; ENST00000225276.10; ENSP00000225276.4; ENSG00000070731.11.
DR   GeneID; 10610; -.
DR   KEGG; hsa:10610; -.
DR   MANE-Select; ENST00000225276.10; ENSP00000225276.4; NM_006456.3; NP_006447.2.
DR   UCSC; uc002jsg.5; human.
DR   AGR; HGNC:10867; -.
DR   CTD; 10610; -.
DR   DisGeNET; 10610; -.
DR   GeneCards; ST6GALNAC2; -.
DR   HGNC; HGNC:10867; ST6GALNAC2.
DR   HPA; ENSG00000070731; Low tissue specificity.
DR   MIM; 610137; gene.
DR   neXtProt; NX_Q9UJ37; -.
DR   OpenTargets; ENSG00000070731; -.
DR   PharmGKB; PA35769; -.
DR   VEuPathDB; HostDB:ENSG00000070731; -.
DR   eggNOG; KOG2692; Eukaryota.
DR   GeneTree; ENSGT00940000160433; -.
DR   HOGENOM; CLU_032020_0_0_1; -.
DR   InParanoid; Q9UJ37; -.
DR   OMA; MGSPHWK; -.
DR   OrthoDB; 5348004at2759; -.
DR   PhylomeDB; Q9UJ37; -.
DR   TreeFam; TF354325; -.
DR   BRENDA; 2.4.99.3; 2681.
DR   PathwayCommons; Q9UJ37; -.
DR   Reactome; R-HSA-4085001; Sialic acid metabolism.
DR   Reactome; R-HSA-9683673; Maturation of protein 3a.
DR   Reactome; R-HSA-9694548; Maturation of spike protein.
DR   Reactome; R-HSA-9694719; Maturation of protein 3a.
DR   Reactome; R-HSA-977068; Termination of O-glycan biosynthesis.
DR   SignaLink; Q9UJ37; -.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 10610; 7 hits in 1137 CRISPR screens.
DR   ChiTaRS; ST6GALNAC2; human.
DR   GeneWiki; ST6GALNAC2; -.
DR   GenomeRNAi; 10610; -.
DR   Pharos; Q9UJ37; Tbio.
DR   PRO; PR:Q9UJ37; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9UJ37; protein.
DR   Bgee; ENSG00000070731; Expressed in tibial nerve and 98 other tissues.
DR   ExpressionAtlas; Q9UJ37; baseline and differential.
DR   Genevisible; Q9UJ37; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0001665; F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0008373; F:sialyltransferase activity; TAS:Reactome.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0006486; P:protein glycosylation; IDA:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB.
DR   GO; GO:1990743; P:protein sialylation; IDA:UniProtKB.
DR   GO; GO:0019082; P:viral protein processing; TAS:Reactome.
DR   Gene3D; 3.90.1480.20; Glycosyl transferase family 29; 1.
DR   InterPro; IPR001675; Glyco_trans_29.
DR   InterPro; IPR038578; GT29-like_sf.
DR   InterPro; IPR012163; Sialyl_trans.
DR   PANTHER; PTHR45941; -; 1.
DR   PANTHER; PTHR45941:SF5; ALPHA-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 2; 1.
DR   Pfam; PF00777; Glyco_transf_29; 1.
DR   PIRSF; PIRSF005557; Sialyl_trans; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; Glycoprotein; Glycosyltransferase;
KW   Golgi apparatus; Membrane; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..374
FT                   /note="Alpha-N-acetylgalactosaminide alpha-2,6-
FT                   sialyltransferase 2"
FT                   /id="PRO_0000149272"
FT   TOPO_DOM        1..7
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        8..28
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        29..374
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   BINDING         156
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /evidence="ECO:0000269|PubMed:29251719,
FT                   ECO:0007744|PDB:6APL"
FT   BINDING         179
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /evidence="ECO:0000269|PubMed:29251719,
FT                   ECO:0007744|PDB:6APL"
FT   BINDING         304
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /evidence="ECO:0000269|PubMed:29251719,
FT                   ECO:0007744|PDB:6APL"
FT   BINDING         336
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /evidence="ECO:0000269|PubMed:29251719,
FT                   ECO:0007744|PDB:6APL"
FT   CARBOHYD        85
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29251719,
FT                   ECO:0007744|PDB:6APL"
FT   CARBOHYD        130
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29251719,
FT                   ECO:0007744|PDB:6APL"
FT   CARBOHYD        161
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29251719,
FT                   ECO:0007744|PDB:6APL"
FT   DISULFID        66..148
FT                   /evidence="ECO:0000269|PubMed:29251719,
FT                   ECO:0007744|PDB:6APJ, ECO:0007744|PDB:6APL"
FT   DISULFID        151..317
FT                   /evidence="ECO:0000269|PubMed:29251719,
FT                   ECO:0007744|PDB:6APJ, ECO:0007744|PDB:6APL"
FT   CONFLICT        11
FT                   /note="L -> V (in Ref. 2; AAA52228)"
FT                   /evidence="ECO:0000305"
FT   HELIX           70..76
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           78..81
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           94..96
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           99..105
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           110..112
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           119..128
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           132..135
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   STRAND          150..154
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           158..160
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   TURN            161..163
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           166..171
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   STRAND          172..180
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   TURN            184..186
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           187..190
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   STRAND          195..199
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           201..210
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   TURN            212..215
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   STRAND          226..229
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           234..245
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   TURN            253..256
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           259..263
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   TURN            269..271
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   STRAND          272..275
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           277..286
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           305..316
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   STRAND          318..324
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   HELIX           328..332
FT                   /evidence="ECO:0007829|PDB:6APL"
FT   STRAND          339..341
FT                   /evidence="ECO:0007829|PDB:6APJ"
FT   HELIX           353..365
FT                   /evidence="ECO:0007829|PDB:6APL"
SQ   SEQUENCE   374 AA;  41939 MW;  E0BD439E4C6BB427 CRC64;
     MGLPRGSFFW LLLLLTAACS GLLFALYFSA VQRYPGPAAG ARDTTSFEAF FQSKASNSWT
     GKGQACRHLL HLAIQRHPHF RGLFNLSIPV LLWGDLFTPA LWDRLSQHKA PYGWRGLSHQ
     VIASTLSLLN GSESAKLFAP PRDTPPKCIR CAVVGNGGIL NGSRQGPNID AHDYVFRLNG
     AVIKGFERDV GTKTSFYGFT VNTMKNSLVS YWNLGFTSVP QGQDLQYIFI PSDIRDYVML
     RSAILGVPVP EGLDKGDRPH AYFGPEASAS KFKLLHPDFI SYLTERFLKS KLINTHFGDL
     YMPSTGALML LTALHTCDQV SAYGFITSNY WKFSDHYFER KMKPLIFYAN HDLSLEAALW
     RDLHKAGILQ LYQR
//
